Clinical trials: Erbium YAG Laser
Healthy
Re-epithelialization Efficacy Evaluation of Cosmetic Product RV1551P vs Non-treated Forearm of Healthy Adult Women
The aim of this study was to evaluate the impact of the product RV1551P GB3224 on skin microbiota during wound healing process, based on swab samples collected from lesion areas using an epidermally ablated skin model of erbium…
- Trial name
- NCT06387277
- Testing
- RV1551P GB3224
- Where
- France
- Volunteers
- 21 people
- Sponsor
- Pierre Fabre Dermo Cosmetique
Refractory Melasma
Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid
Melasma is a common acquired disorder of hyperpigmentaion caused by increased melanin production by melanocytes. Melasma is a name derived from the Greek word melas meaning black.It is characterized by the appearance of brownish…
- Trial name
- NCT06522984
- Testing
- Tranexamic acid injection
- Where
- Egypt
- Volunteers
- 45 people
- Sponsor
- Egymedicalpedia
Healthy
Assessment of the Effect of the Product RV2666C Formula LA2984 Compared to an Untreated Area With an Epidermally Ablated Skin Model Obtained With an Erbium YAG Laser on Adults Presenting IV to VI Skin Phototype
In this study, we assess the efficacy of a cosmetic product in adults with IV to VI skin phototype. This study is conducted as a monocentric, controlled, compared with an untreated area and randomized for the area of product…
- Trial name
- NCT07166484
- Testing
- Cosmetic product RV2666C LA2984
- Where
- France
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- Pierre Fabre Dermo Cosmetique
Alopecia Areata
Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser
Alopecia areata (AA) an autoimmune disorder of hair follicles results in varying degrees of scalp, facial and body hair loss. Clinically, patients' presentation varies from patchy circumscribed scalp involvement to total body and…
- Trial name
- NCT06239324
- Testing
- Latanoprost
- Where
- Egypt
- Volunteers
- 70 people
- Sponsor
- Egymedicalpedia